Avtor/Urednik		Čufer, Tanja; Vrdoljak, Eduard; Gaafar, Rabab; Erensoy, Inci; Pomberton, Kristine
Naslov		Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (Iressa) of docetaxel as second-line theapy in patients with advanced (stage IIIB of IV) non-small-cell lung cancer
Tip		članek
Vir		In: Approaches to Better Survival and Quality of Life in Cancer. Joint International Conference of NCI Egypt, EORTC and MMOF (Lung and Breast Cancer); 2010 Oct 29-31; Cairo. Cairo: Cairo University, National Cancer Institute,
Leto izdaje		2010
Obseg		str. 101-2
Jezik		eng